Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Weight Gain and ABCB1[original query] |
---|
Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2016 Sep . Vasudev Kamini, Choi Yun-Hee, Norman Ross, Kim Richard B, Schwarz Ute |
Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians. The pharmacogenomics journal 2016 Nov . Vendelbo J, Olesen R H, Lauridsen J K, Rungby J, Kleinman J E, Hyde T M, Larsen |
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapine. Pharmacogenomics and personalized medicine 2017 10 235-242. Piatkov Irina, Caetano Dorgival, Assur Yolinda, Lau Sue Lynn, Jones Trudi, Boyages Steven C, McLean Ma |
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Advances in therapy 2020 Dec . Koller Dora, Almenara Susana, Mejía Gina, Saiz-Rodríguez Miriam, Zubiaur Pablo, Román Manuel, Ochoa Dolores, Navares-Gómez Marcos, Santos-Molina Elena, Pintos-Sánchez Elena, Abad-Santos Francis |
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in pharmacology 2021 8 12 711940. Soria-Chacartegui Paula, Villapalos-García Gonzalo, Zubiaur Pablo, Abad-Santos Francisco, Koller Do |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: